✦ LIBER ✦

Comparison of iodixanol and ioxaglate for adult aortography and renal/visceral angiography: A phase III clinical trial

✍ Scribed by Siegel, Edward L.; Rosenblum, Jordan D.; Eckard, Donald A.; Leef, Jeffrey; Bergh, James; Parsa, Michael B.; Redick, Mark L.

Book ID: 123240757
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 645 KB
Volume: 3
Category: Article
ISSN: 1076-6332
DOI: 10.1016/S1076-6332(05)80367-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of gadodiamide-enhanced MR an

Comparison of gadodiamide-enhanced MR angiography to intraarterial digital subtraction angiography for evaluation of renal artery stenosis: Results of a phase III multicenter trial

✍ Vesna D. Garovic; Manuela A. Achauer; Thomas Kittner; David Horák; Rubin Sheng; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

## Abstract ## Purpose: To evaluate the efficacy and safety of 0.1 mmol/kg gadodiamide administration for contrast‐enhanced magnetic resonance angiography (MRA) in detecting hemodynamically relevant renal artery stenosis (RAS) when compared with intraarterial digital subtraction angiography (IA‐DS

Comparison of contrast-enhanced MR angio

Comparison of contrast-enhanced MR angiography to intraarterial digital subtraction angiography for evaluation of peripheral arterial occlusive disease: Results of a phase III multicenter trial

✍ Bao T. Bui; Stephan Miller; Peter Mildenberger; Albert Sam II; Rubin Sheng 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 251 KB

## Abstract ## Purpose To evaluate the efficacy and safety of 0.1 mmol/kg gadodiamide administration for contrast‐enhanced magnetic resonance angiography (CE‐MRA) in detecting hemodynamically relevant main stenosis (ie, ≥50% or occlusion) of aortoiliac arteries. ## Materials and Methods In a mul

Efficacy and safety of linagliptin in ty

Efficacy and safety of linagliptin in type 2 diabetes subjects at high risk for renal and cardiovascular disease: a pooled analysis of six phase III clinical trials

✍ von Eynatten, Maximilian; Gong, Yan; Emser, Angela; Woerle, Hans-Juergen 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 562 KB

1133-156 Results of four multicenter, ph

1133-156 Results of four multicenter, phase III, magnetic resonance angiography (MRA) trials with MS-325, a blood pool contrast agent, for the detection of vascular disease in the aortoiliac, renal, and pedal regions

✍ Emile R Mohler III 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 276 KB

Randomized phase II/III trial of interfe

Randomized phase II/III trial of interferon alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell carcinoma: The European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951): Aass N, De Mulder PHM, Mickisch GHJ, Mulders P, van Oosterom AT, van Poppel H, Fossa SD, de Prijck L, Sylvester RJ, Department of Clinical Cancer Research, The Norwegian Radium Hospital, Oslo, Norway

✍ Robert Flanigan 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 42 KB